Paeonia Lactiflora Extract

Main Active Ingredient:
Paeoniflorin — CAS: 23180-57-6 | Assay: 10% / 30% / 50% / 98% Paeoniflorin (HPLC)|Peeled Root (Bai Shao 白芍)
Ratio Extracts — 4:1 / 10:1 /20:1
Application: anti-inflammatory & immune-support supplements | mood & stress-support formulas | neuroprotective & cognitive stacks | cosmeceutical skin-brightening actives | TCM formula ingredients | nutraceutical ingredient applications
MOQ: 1KG
Certifications: ISO, HACCP, GMP, Kosher, Halal, Organic, BRC, FDA Registered Facility, Third-Party COA

Thank you for sharing our article through the button

Facebook
X
LinkedIn
Telegram
Reddit

Bulk Paeonia lactiflora Extract Supplier — Paeoniflorin 10%–98% HPLC & 4:1 / 10:1 / 20:1 Ratio Extracts, B2B Wholesale

Written by Jonathan, Valeherb · Reviewed by Dr. Xiaoyan Qiu · Updated June 2026

Valeherb supplies Paeonia lactiflora extract bulk wholesale — Bai Shao (白芍, White Peony Root) — in two product lines: paeoniflorin-standardized grades (10%, 30%, 50%, and 98% by HPLC) and concentration-ratio extracts (4:1, 10:1, and 20:1), with custom specifications available for anti-inflammatory, neuroprotective, and cosmeceutical formulation. Derived from the peeled, dried root of Paeonia lactiflora Pall. (Paeoniaceae), this extract has over 2,000 years of documented use in traditional Chinese medicine and a well-characterised modern pharmacological evidence base centred on paeoniflorin — a monoterpene glycoside that is both the primary active compound and the Chinese Pharmacopoeia (ChP 2020) HPLC quality marker for Radix Paeoniae Alba.[1]

On this page: Bai Shao vs Chi Shao distinction, available grades, active compound profile, research background, formulation applications, sourcing criteria, regulatory guidance, and references.


Bai Shao vs Chi Shao: The Procurement Distinction

Two commercially distinct peony root types share the same botanical species — Paeonia lactiflora Pall. — but are processed differently and have separate ChP 2020 monographs with different applications.

Property Bai Shao 白芍 (White Peony Root) Chi Shao 赤芍 (Red Peony Root)
Processing Roots peeled, boiled, and dried — skin removed Roots unpeeled, dried raw — skin retained
Primary active compound Paeoniflorin — typically 2–4% in raw root; concentrated to 10–98% in extract Paeoniflorin + paeonol; different ratio and profile from Bai Shao
ChP 2020 monograph Radix Paeoniae Alba (白芍) — paeoniflorin ≥1.6% by HPLC Radix Paeoniae Rubra (赤芍) — paeoniflorin ≥1.8% by HPLC; separate monograph
TCM classification Blood-nourishing, liver-soothing, yin-tonifying herb Blood-invigorating, heat-clearing, blood-stasis-resolving herb
Primary research focus Anti-inflammatory, neuroprotective, immunomodulatory, antioxidant activity[1] Vascular biology, hepatoprotective, antioxidant activity
Cosmeceutical use Tyrosinase inhibition, antioxidant, skin-brightening — INCI: Paeonia Lactiflora Root Extract Less commonly used in cosmetic formulations
SOURCING NOTE
Valeherb supplies Bai Shao (Paeonia lactiflora, peeled root) for paeoniflorin-standardized and ratio extract applications. Chi Shao (unpeeled root) is available on request. The two have different paeoniflorin profiles and different regulatory documentation under ChP 2020 — specify which is required on the purchase order. For supplement and cosmeceutical applications, Bai Shao is the standard commercial specification.

Available Grades and Specifications

Paeoniflorin-Standardized Extracts — Guaranteed Marker Content

Grade Paeoniflorin Content Assay Method Typical Application
Standard Extract 10% paeoniflorin HPLC Entry-level anti-inflammatory blends, TCM-format supplements, herbal tonic capsules
Mid-Potency Extract 30% paeoniflorin HPLC Mainstream immune-support and adaptogenic capsules; mood and stress-support formulas
High-Potency Extract 50% paeoniflorin HPLC Premium anti-inflammatory stacks; cosmeceutical actives; compact dosing applications
Purified Paeoniflorin 98% paeoniflorin HPLC Pharmaceutical-adjacent applications; precision-dosed research applications; high-end cosmetic actives

Ratio Extracts — 4:1 / 10:1 / 20:1

Full-spectrum whole-root extracts retaining paeoniflorin alongside albiflorin, oxypaeoniflorin, benzoylpaeoniflorin, and the polysaccharide fraction. Paeoniflorin content is reported as-tested per batch.

Grade (Ratio) Concentration Profile Typical Application
4:1 Full-spectrum — paeoniflorin + albiflorin + polysaccharides Classical TCM tonic blends, traditional Bai Shao formulas, entry-level supplements
10:1 Concentrated full-spectrum; higher paeoniflorin density Mainstream anti-inflammatory and immune-support capsules; adaptogen blends
20:1 High active density per gram Premium stacks; cosmeceutical serums; compact dosing formats

Custom ratios and dual-compound (paeoniflorin + albiflorin) standardized grades available on request. MOQ, lead time, and current pricing available on inquiry.


Active Compounds

Compound Class Notes
Paeoniflorin Monoterpene glycoside — primary ChP marker; water-soluble Principal bioactive; CAS 23180-57-6; MW 480.46; ChP 2020 HPLC quality marker (≥1.6% in raw root); most extensively studied compound in published research[1]
Albiflorin Monoterpene glycoside — secondary marker Stereoisomer of paeoniflorin; present at approximately 30–50% of paeoniflorin levels in raw root; immunomodulatory and neuroprotective activity studied independently in published research
Oxypaeoniflorin Monoterpene glycoside Present in raw root at low levels; antioxidant activity studied in published research
Benzoylpaeoniflorin Monoterpene glycoside Minor compound; present in both Bai Shao and Chi Shao; studied for smooth muscle modulation activity in published research
Polysaccharides Complex carbohydrate fraction Immunomodulatory activity studied in published research; concentrated in aqueous extracts and ratio grades

Research Background

The activity described below is reported in published research on Paeonia lactiflora extract and its constituent compounds. It is provided as scientific context for formulators, not as claims for any Valeherb product.

1. Anti-Inflammatory and Immunomodulatory Activity — Comprehensive Review

Zhou et al. (2020, Biomedicine & Pharmacotherapy) reviewed paeoniflorin’s pharmacokinetics and anti-inflammatory and immunomodulatory effects. The review documented modulation of NF-κB, MAPK, and TLR4 signaling pathways with reduced pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6) across multiple in vitro and in vivo models. Oral bioavailability is relatively low — a relevant formulation consideration for delivery system design.[1]

2. Neuroprotective Activity — Nervous System Review

Hong et al. (2022, Frontiers in Pharmacology) reviewed paeoniflorin’s pharmacological effects in the nervous system, documenting antioxidant effects via Nrf2/HO-1 pathway activation, neuroinflammation inhibition via TLR4/NF-κB/NLRP3 modulation, and neuroprotective activity against oxidative-stress-induced neuronal damage in published preclinical models.[2]

3. Antidepressant-Like Activity — Preclinical Models

Wang et al. (2021, Phytomedicine) reviewed paeoniflorin’s neuroprotective and antidepressant-like properties, documenting activity in chronic unpredictable mild stress (CUMS) animal models including restoration of hippocampal neuroplasticity and HPA axis modulation. The authors noted limited clinical evidence in humans at the time of publication.[3]

4. Pharmacokinetics and Multi-Organ Protective Mechanisms

Tian et al. (2021, Frontiers in Pharmacology) reviewed paeoniflorin’s pharmacokinetic properties and protective mechanisms across neurological, cardiovascular, and renal research models, confirming inhibitory effects on inflammation, fibrosis, and apoptosis via intracellular signaling modulation. Low oral bioavailability was noted as a formulation challenge, with phospholipid complexes and nanoparticle delivery systems proposed as solutions.[4]


Formulation Applications

  • Anti-inflammatory and immune-support supplements: 30% or 50% grade at 200–500 mg per serving. Pairs with boswellia, curcumin, and andrographis; or with astragalus and Poria cocos in TCM-positioned immune blends
  • Stress support and mood formulas: 10:1 or 30% grade in adaptogen and calm-support formulas. Combines with Suanzaoren extract and Polygala tenuifolia in Xiaoyao-San-inspired TCM blends
  • Neuroprotective and cognitive stacks: 50% or higher grade with lion’s mane and Bacopa monnieri, based on published Nrf2/HO-1 and neuroinflammation-modulation activity in preclinical research
  • Cosmeceutical actives: 50% or 98% grade in skin-brightening serums and anti-aging topicals. Published tyrosinase inhibitory and antioxidant activity in skin-cell models. INCI: Paeonia Lactiflora Root Extract
  • TCM-format supplements: 4:1 full-spectrum extract in classical Bai Shao formula blends; ChP 2020 compliance documentation available

Sourcing Criteria

Criterion What to Require
Species & Processing Confirmation Paeonia lactiflora Pall., peeled root (Bai Shao) confirmed on COA. Distinguish from unpeeled Chi Shao — different processing, different compound profile, separate ChP monograph
Paeoniflorin Content HPLC-verified paeoniflorin percentage per batch — the ChP 2020 primary quality marker. For cosmeceutical applications, request HPLC chromatogram showing paeoniflorin peak alongside albiflorin for full-spectrum compound confirmation
Ratio & Extraction Format Confirm stated ratio (4:1 / 10:1 / 20:1) against raw-to-finished input. Aqueous extraction for polysaccharide-inclusive full-spectrum; ethanol for higher paeoniflorin concentration per gram
Third-Party COA Paeoniflorin content (HPLC), heavy metals (USP <232>), pesticide residues (multi-residue screen), microbial limits (USP <2021>), moisture — per production batch from accredited laboratory
Certifications Non-GMO, Kosher/Halal for relevant markets; FDA-registered facility for US supply chains; ChP 2020 documentation for China domestic market
CAUTION
Paeonia lactiflora root extract is generally well-tolerated at standard supplement doses in published literature. Key label considerations for finished-product formulators: paeoniflorin has published immunomodulatory activity — precautionary disclosure recommended for individuals on immunosuppressant medications. Aromatase-related and hormone-pathway modulating activity has been studied in published preclinical research — precautionary disclosure for individuals with hormone-sensitive conditions is recommended; avoid in individuals on hormone therapy without healthcare professional consultation. Not recommended during pregnancy — insufficient controlled clinical data in pregnancy warrant precautionary avoidance. Mild GI discomfort (nausea) reported at higher doses; manageable with food co-administration. Rare cases of allergic reaction in individuals with known Paeoniaceae family sensitivity.

Regulatory Guidance

  • US (DSHEA): Anti-inflammatory support, immune support, and antioxidant structure/function claims are supportable with published research — each must be self-substantiated by the marketer and carry the required FDA disclaimer. Disease treatment claims require drug approval. FDA-registered facility (21 CFR Part 111)
  • China (ChP 2020): Radix Paeoniae Alba (白芍) is a listed medicinal herb with standardized ChP 2020 monograph, specifying paeoniflorin ≥1.6% by HPLC as the quality marker. ChP compliance documentation available for both domestic and export use
  • Cosmetics (EU/US): INCI name is Paeonia Lactiflora Root Extract. Listed in EU Cosing database. Confirm safety assessment under EU Cosmetics Regulation 1223/2009 for your specific formulation and concentration
  • EU (supplements): Not currently on the EU authorized health claims register. Traditional use status may apply in some member states — confirm with regulatory counsel before finalizing EU-market product claims
  • Canada (NHPs): Bai Shao (White Peony Root) is recognized in Traditional Chinese Medicine under Natural Health Products Regulations — confirm permitted claim language with a qualified Canadian regulatory consultant

FAQ

A1:Both derive from Paeonia lactiflora Pall. but are processed differently and have separate ChP 2020 monographs. Bai Shao is peeled, boiled, and dried — concentrating the paeoniflorin profile. Chi Shao is unpeeled and dried raw, giving a different compound ratio with more paeonol. For paeoniflorin-standardized supplement and cosmeceutical applications, Bai Shao is the standard specification.
A2:The percentage reflects HPLC-verified paeoniflorin content per gram. The 10% grade retains the full-spectrum compound matrix suited to TCM tonic blends. The 30% grade is the mainstream choice for immune-support, mood, and stress capsules. The 50% grade is used for premium anti-inflammatory stacks and cosmeceutical actives. The 98% grade is purified paeoniflorin for pharmaceutical-adjacent and precision cosmetic applications.
A3:Paeoniflorin (CAS 23180-57-6) is a water-soluble monoterpene glycoside and the primary bioactive of Paeonia lactiflora root — the ChP 2020 HPLC quality marker for Radix Paeoniae Alba. Published research has documented anti-inflammatory activity via NF-κB and MAPK pathway modulation, antioxidant activity via Nrf2/HO-1 activation, and immunomodulatory effects in preclinical models. Note that oral bioavailability is relatively low; delivery system design (phospholipid complexes, nanoparticles) can improve absorption.
A4:Anti-inflammatory and immune-support capsules (30%–50% grade, pairs with boswellia and curcumin); TCM mood and stress-support formulas (10:1 or 30% grade, pairs with Suanzaoren and Polygala tenuifolia); neuroprotective stacks (50% grade, pairs with lion’s mane and Bacopa); cosmeceutical skin-brightening actives (50% or 98% grade, INCI: Paeonia Lactiflora Root Extract).

SEND INQUIRY

Contact Form Demo

The essence of natural sweetness — extracted directly from plants

The most promising sugar-free and zero-calorie sweetener usage guide for 2026

Understand the gap between natural sweeteners and synthetic sweeteners